Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis

P. Katz, A. S. Fauci

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The present study employed a direct plaque-forming cell (PFC) assay following pokeweed mitogen (PWM) induced polyclonal activation of B lymphocytes in sarcoidosis to evaluate the in vitro humoral immune response in this disease and to delineate the immunoregulation of this response. Sarcoidosis lymphocytes had a suppressed PFC response to polyclonal activation, but were unable to suppress normal B-cell PFC responses in allogeneic co-cultures. Removal of a cell type, which was corticosteroid-resistant, radio-resistant, adherent and a non-T cell, from sarcoidosis mononuclear cell suspensions reversed the suppressed PFC response, indicating the presence of a suppressor monocyte. Thus in vitro suppressor cell activity has now been demonstrated in this disease, which is characterized by multiple immunological aberrancies.

Original languageEnglish
Pages (from-to)554-562
Number of pages9
JournalClinical and Experimental Immunology
Volume32
Issue number3
StatePublished - Dec 1 1978
Externally publishedYes

Fingerprint

Sarcoidosis
Monocytes
B-Lymphocytes
Pokeweed Mitogens
Humoral Immunity
Coculture Techniques
Radio
Suspensions
Adrenal Cortex Hormones
Lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. / Katz, P.; Fauci, A. S.

In: Clinical and Experimental Immunology, Vol. 32, No. 3, 01.12.1978, p. 554-562.

Research output: Contribution to journalArticle

@article{13d3de5014614c41b3accf0a429835d5,
title = "Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis",
abstract = "The present study employed a direct plaque-forming cell (PFC) assay following pokeweed mitogen (PWM) induced polyclonal activation of B lymphocytes in sarcoidosis to evaluate the in vitro humoral immune response in this disease and to delineate the immunoregulation of this response. Sarcoidosis lymphocytes had a suppressed PFC response to polyclonal activation, but were unable to suppress normal B-cell PFC responses in allogeneic co-cultures. Removal of a cell type, which was corticosteroid-resistant, radio-resistant, adherent and a non-T cell, from sarcoidosis mononuclear cell suspensions reversed the suppressed PFC response, indicating the presence of a suppressor monocyte. Thus in vitro suppressor cell activity has now been demonstrated in this disease, which is characterized by multiple immunological aberrancies.",
author = "P. Katz and Fauci, {A. S.}",
year = "1978",
month = "12",
day = "1",
language = "English",
volume = "32",
pages = "554--562",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis

AU - Katz, P.

AU - Fauci, A. S.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - The present study employed a direct plaque-forming cell (PFC) assay following pokeweed mitogen (PWM) induced polyclonal activation of B lymphocytes in sarcoidosis to evaluate the in vitro humoral immune response in this disease and to delineate the immunoregulation of this response. Sarcoidosis lymphocytes had a suppressed PFC response to polyclonal activation, but were unable to suppress normal B-cell PFC responses in allogeneic co-cultures. Removal of a cell type, which was corticosteroid-resistant, radio-resistant, adherent and a non-T cell, from sarcoidosis mononuclear cell suspensions reversed the suppressed PFC response, indicating the presence of a suppressor monocyte. Thus in vitro suppressor cell activity has now been demonstrated in this disease, which is characterized by multiple immunological aberrancies.

AB - The present study employed a direct plaque-forming cell (PFC) assay following pokeweed mitogen (PWM) induced polyclonal activation of B lymphocytes in sarcoidosis to evaluate the in vitro humoral immune response in this disease and to delineate the immunoregulation of this response. Sarcoidosis lymphocytes had a suppressed PFC response to polyclonal activation, but were unable to suppress normal B-cell PFC responses in allogeneic co-cultures. Removal of a cell type, which was corticosteroid-resistant, radio-resistant, adherent and a non-T cell, from sarcoidosis mononuclear cell suspensions reversed the suppressed PFC response, indicating the presence of a suppressor monocyte. Thus in vitro suppressor cell activity has now been demonstrated in this disease, which is characterized by multiple immunological aberrancies.

UR - http://www.scopus.com/inward/record.url?scp=0018114511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018114511&partnerID=8YFLogxK

M3 - Article

C2 - 357055

AN - SCOPUS:0018114511

VL - 32

SP - 554

EP - 562

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 3

ER -